Insights from Digital Pharma Leaders
Refine Search
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Biotechnology
Japanese drugmaker Ono Pharmaceutical has signed a drug discovery research collaboration with twoXAR, a USA-based artificial intelligence (AI)-driven biopharmaceutical company, to jointly discover and develop novel, efficacious treatments to address unmet medical needs in a specific neurological disease. 19 March 2019
Pharmaceutical
PureTech Health today announced that its independent affiliate Akili has entered into a strategic partnership with Japan’s Shionogi for the commercialization of two of Akili’s digital medicine product candidates. 7 March 2019
Pharmaceutical
Adhera Therapeutics and Alyvant, yesterday announced a digital co-promotion agreement for Prestalia (perindopril arginine and amlodipine) therapy for the treatment of hypertension. 5 March 2019
Pharmaceutical
Drugmaker Cipla is to acquire an 11.7% stake in digital therapeutics company Wellthy Therapeutics. 19 February 2019
Pharmaceutical
Boehringer Ingelheim has shown faith in the potential of blockchain. 12 February 2019
Pharmaceutical
Sanofi, UCB and leading US insurer BlueCross BlueShield are among the new strategic shareholders in Aetion, a tech company with a real-world analytics and evidence platform to engage in value-based care. 5 February 2019
Pharmaceutical
Today, the first patients in the European Union can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. 21 January 2019
Pharmaceutical
Swiss pharma giant Novartis (NOVN: VX) is to work with the University of Oxford’s Big Data Institute (BDI) to improve drug research and development using artificial intelligence (AI). 18 January 2019
Pharmaceutical
US Food and Drug Administration Commissioner Scott Gottlieb has provided an update on the agency’s new actions under the Digital Health Precertification (Pre-Cert) Program. 8 January 2019
Pharmaceutical
Peter Guenter has sought to keep up the pace of his turnaround of Spanish dermatology specialist Almirall. 4 January 2019
Pharmaceutical
Japanese drugmaker Otsuka Pharmaceutical has become the latest pharma company to show faith in a US firm that develops software to address unmet medical need. 4 January 2019
Pharmaceutical
Does the way artificial intelligence is used in pharma need to be reimagined? Irina Efimenko, chief executive of Russian analytics experts Semantic Hub, and Mike Samsonov, chief medical officer of R-Pharm, consider this question in an Expert View piece. 20 December 2018
Pharmaceutical
Danish diabetes company Novo Nordisk has signed a research collaboration with e-therapeutics, a UK-based company with a computer-based drug discovery platform. 10 December 2018
Pharmaceutical
A new pharma-partnered project has been set up to build a large-scale, federated network of data sources standardized to a common model. 23 November 2018
Pharmaceutical
For the era of personalized therapies to truly arrive, industry observers often express the view that pharma will have to improve its understanding not just of biology and medicines, but also of certain new technologies that are likely to determine companies’ future way of working. 30 October 2018
Pharmaceutical
Russia’s arrival as a major player in the digitalization of healthcare was abundantly clear at a Moscow event held to celebrate and stimulate advances in the sector. 25 October 2018
Pharmaceutical
Denmark’s Novo Nordisk and French pharma major Sanofi lead the pack when it comes to delivering a standout online experience to US patients in the crowded marketplace for type 2 diabetes treatments, a study from DRG Digital Manhattan Research reveals. 23 October 2018
Pharmaceutical
Sumitomo Dainippon Pharma has announced a 700 million yen ($6 million) investment in a company that aims to enhance the functionality of cyborg technologies and the combination of bio-signal processing and robotics. 17 October 2018
Pharmaceutical
In a special report piece, Ed Corbett, principal at specialist pharmaceutical strategy consultants, Novasecta, considers an issue of paramount importance to the future of the industry. 3 October 2018
Pharmaceutical
A cloud-based informatics platform being launched by US pharma giant Merck & Co and Accenture has been launched with the claim that it will improve productivity, efficiency and innovation in the early stages of drug development. 20 September 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze